Private Market View

Calibrate

New York, NY · Founded 2019 · Privately Held (backing)

Last price · $/share
Implied valuation
$388.6M
Total raised
$170.1M
Last round

Key facts

  • Calibrate’s last known valuation is $388.6M (Oct 2023).
  • It has raised $170.1M; the latest was PE Growth/Expansion in May 2025.
  • Notable investors include Mana Ventures, Gaingels, Founders Fund, Forerunner Ventures, What If Ventures11 tracked in total.
  • 1 investment vehicle was formed to buy Calibrate shares in the last 12 months, reporting $5.1M sold to 2 investors, per SEC Form D filings.
  • Status: Privately Held (backing).
Free account
See the evidence behind this price
  • ·The complete investor list — 11 names
  • ·Watchlist + deal alerts for Calibrate
  • ·The full record, as it builds
Create free account
No card required

Funding rounds

No rounds on record

No funding rounds for Calibrate are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Secondary demand: investment vehicles

from SEC Form D filings

In the last 12 months, 1 investment vehicle were formed to buy Calibrate shares, reporting $5.1M sold to 2 investors. Most recent filing May 2026. Vehicles like these are how secondary buyers pool demand for a name; a rising count is a demand signal.

The vehicle list — each sponsor, filing date, amount sold and investor count — is a Pro table. Unlock the 1 vehicle

About Calibrate

Developer of a weight management platform designed to improve metabolic health to drive long-term and sustainable weight loss. The company's platform offers telemedicine metabolic medications with purpose-built behavior change to catalyze the physiological changes for vital sustained metabolic health care medication outcomes-based model in obesity treatment and offers value-based pricing to control GLP-1(glucagon-like peptide-1), one-on-one video doctor visits, and personal coaching, enabling patients to lose their body weight and stay fit and healthy.

Sector
Healthcare
HQ
New York, NY, United States
Founded
2019
Employees
366
Ownership
Privately Held (backing)
PA Mark — not yet priced

Calibrate doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.

Recorded secondary trades

No prints on record

No secondary trades in Calibrate shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.

Pro members can request priority coverage with a 48-hour turnaround.

Institutional fund marks

No fund marks yet

No SEC-registered fund has reported a fair-value mark on Calibrate in its N-PORT filings yet. We sweep new filings monthly.

Pro members can request priority coverage with a 48-hour turnaround.